FOXK2 and Parkinson disease: It is clear that more evidence is needed to better clarify the casual relationship between ILF neurodegeneration and PD symptomatology and other potential markers especially in the early stages of the disease, which offer the greatest opportunity to apply neuroprotective measures and halt the neurodegenerative process.